02:20 PM EST, 02/26/2025 (MT Newswires) -- Silo Pharma ( SILO ) said Wednesday the US Patent and Trademark Office issued a notification for its "Pharmacological Prophylactics Against Stress-Induced Affective Disorders in Females" application.

The patent reinforces protection for its lead asset, SPC-15, an intranasal treatment targeting post-traumatic stress disorder, the company said.

"This new patent further supports our collaborative research with Columbia University and expands coverage for SPC-15," said Chief Executive Officer Eric Weisblum.

Price: 1.36, Change: -0.03, Percent Change: -2.16